🟢 Moleculin Biotech is trading 6.1% up today — no clear company-specific catalyst identified

Moleculin Biotech is trading at $0.61, up 6.07%, with the gain appearing more likely tied to short-term trading, recent momentum, or volatility.

• No new company-specific announcement or clear catalyst was identified for August 20, 2026.
• The latest reported update was the August 14, 2026 quarterly report, highlighting MIRACLE trial progress and positive interim data.
• Broader equities and biotechnology shares are under pressure.